Startup Feature
ChestPal
ChestPal makes the world’s most advanced AI digital stethoscope to detect and categorize acute and chronic lung sounds.
Location
UK
Founded
2022
Industry Segment
Digital Health, Medical Devices
Team Size
6
About
Summary
ChestPal Pro is a high impact technology being the only digital stethoscope that detects and categorizes both acute and chronic lung sounds for disease detection, and is set to transform the lives of people suffering respiratory conditions.
Helena’s daughter suffered repeated respiratory conditions, with many visits to her GP and hospital, with numerous conflicting diagnoses. Her daughter suffered and she was forced to take time off work to take her for diagnosis and treatment. Helena realized there must be a better way and she created ChestPal.
Problem
Respiratory conditions account for approximately 1 in 3 visits to GPs and Emergency Depts. Pneumonia is the major cause of mortality in many low to middle income countries. Lung Sounds are the most commonly used front-line indicator for respiratory conditions. Using a traditional stethoscope, Lung Sounds sounds can be extremely difficult to hear and categorize, resulting in frequently missed or incorrectly diagnosed respiratory conditions. Avoidable costs associated with respiratory conditions costs the US healthcare system and insurance companies billions each year.
Solution
ChestPal Pro is a patented, highly sensitive digital stethoscope with a highly trained artificial neural network to detect and categorise lung sounds that aid diagnosis of major respiratory conditions, including pneumonia, asthma and COPD. A HIPAA compliant system, Lung Sounds can be easily shared with other clinicians for remote assessment.
About FalconX
FalconX is a leading global B2B accelerator that is committed to helping startups land and expand in global markets. With a focus on supporting early-stage companies, we provide the resources and expertise necessary for startups to succeed on a global scale.
